Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (31)

2023

  1. Novel Experimental Mouse Model to Study Malaria-Associated Acute Kidney Injury

    Pathogens, Vol. 12, Núm. 4

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. “Shikonin inhibits microglia activation and reduces CFA-induced mechanical hyperalgesia in an animal model of pain”

    Biomedicine and Pharmacotherapy, Vol. 150

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

2019

  1. Urinary excretion of parathyroid hormone-related protein correlates with renal function in control rats and rats with cisplatin nephrotoxicity

    American journal of physiology. Renal physiology, Vol. 317, Núm. 4, pp. F874-F880

2018

  1. Impact of altered intestinal microbiota on chronic kidney disease progression

    Toxins, Vol. 10, Núm. 7

2016

  1. Blockage of neonatal leptin signaling induces changes in the hypothalamus associated with delayed pubertal onset and modifications in neuropeptide expression during adulthood in male rats

    Peptides, Vol. 86, pp. 63-71

2014

  1. Consequences of early life stress on the expression of endocannabinoid- related genes in the rat brain

    Behavioural Pharmacology, Vol. 25, Núm. 5-6, pp. 547-556

2012

  1. Analyzing the effects of a single episode of neonatal maternal deprivation on metabolite profiles in rat brain: A proton nuclear magnetic resonance spectroscopy study

    Neuroscience, Vol. 201, pp. 12-19

  2. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

    Kidney International, Vol. 82, Núm. 6, pp. 652-663

  3. The endocannabinoid system in critical neurodevelopmental periods: Sex differences and neuropsychiatric implications

    Journal of Psychopharmacology, Vol. 26, Núm. 1, pp. 164-176

2011

  1. EEG latency analysis for hemispheric lateralisation in Landau-Kleffner syndrome

    Clinical Neurophysiology, Vol. 122, Núm. 2, pp. 244-252

2009

  1. Early maternal deprivation in rats: A proposed animal model for the study of developmental neuroimmunoendocrine interactions

    Annals of the New York Academy of Sciences

  2. Implicación funcional del sistema cannabinoide endógeno en la homeostasis emocional

    Revista de Neurologia, Vol. 48, Núm. 1, pp. 20-26

  3. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies

    Hypertension Research, Vol. 32, Núm. 5, pp. 347-357

2008

  1. Isolation of chick retina cones and study of their diversity based on oil droplet colour and nucleus position

    Cell and Tissue Research, Vol. 332, Núm. 1, pp. 13-24

2007

  1. Influence of aging and enriched environment on motor activity and emotional responses in mice

    Annals of the New York Academy of Sciences

  2. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: A possible neural substrate for functional interactions

    Behavioural Pharmacology, Vol. 18, Núm. 5-6, pp. 375-389

2006

  1. Fcγ receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice

    Circulation Research, Vol. 99, Núm. 11, pp. 1188-1196

  2. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney

    Journal of Nephrology, Vol. 19, Núm. 6, pp. 725-731